Cargando…
The impact of thymectomy in subgroups of Myasthenia gravis patients: a single center longitudinal observation
BACKGROUND: Myasthenia gravis (MG) is a rare neuromuscular disorder. Symptoms can range from ptosis only to life threatening myasthenic crisis. Thymectomy is recommended for anti-acetylcholine receptor-antibody positive patients with early-onset MG. Here, we investigated prognostic factors shaping t...
Autores principales: | Menghesha, Hruy, Schroeter, Michael, Nelke, Christopher, Ruck, Tobias, Schlachtenberger, Georg, Welskop, Clara, Camo, Amina, Heldwein, Matthias, Bennink, Gerardus, Wahlers, Thorsten, Bölükbas, Servet, Doerr, Fabian, Hekmat, Khosro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268481/ https://www.ncbi.nlm.nih.gov/pubmed/37316910 http://dx.doi.org/10.1186/s42466-023-00252-w |
Ejemplares similares
-
Der Stellenwert der Thymektomie ohne Thymom in der Therapie der Myasthenia gravis
por: Menghesha, Hruy, et al.
Publicado: (2021) -
Neoadjuvant chemoimmunotherapy as a potential therapeutic option in NSCLC UICC stage IIIA with multilevel N2 disease
por: Menghesha, Hruy, et al.
Publicado: (2022) -
Stage I and II Small-Cell Lung Cancer—New Challenge for Surgery
por: Doerr, Fabian, et al.
Publicado: (2022) -
Redefining the role of surgery in early small-cell lung cancer
por: Doerr, Fabian, et al.
Publicado: (2022) -
Patients with Pulmonary Metastases from Head and Neck Cancer Benefit from Pulmonary Metastasectomy, A Systematic Review
por: Schlachtenberger, Georg, et al.
Publicado: (2022)